PMA P030004S035

Device
Onyx Liquid Embolic System (LES)
Applicant
Ev3 Neurovascular
PMA number
P030004
Supplement
S035
Product code
SGU
Decision date
2025-12-08
Classification
Neurology
Generic name
Neurovascular Liquid Embolic Agent
Approval order statement
Onyx Liquid Embolic System (LES) is indicated for embolization of the middle meningeal artery (MMA) as an adjunct to surgery for the treatment of symptomatic subacute or chronic subdural hematoma (SDH).

Current openFDA PMA Record#

Device
Onyx Liquid Embolic System (LES)
Applicant
Ev3 Neurovascular
PMA number
P030004
Supplement
S035
Product code
SGU
Generic name
Neurovascular Liquid Embolic Agent
Decision date
2025-12-08
Decision code
APPR
Date received
2024-10-15
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Onyx Liquid Embolic System (LES) is indicated for embolization of the middle meningeal artery (MMA) as an adjunct to surgery for the treatment of symptomatic subacute or chronic subdural hematoma (SDH).